Zurcher Kantonalbank (Zurich Cantonalbank) Galapagos Nv Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$37.44 - $46.51 $3,144 - $3,906	-84 Reduced 16.12%	437 $19,000
Q2 2022 Aug 09, 2022	SELL	$52.3 - $71.59 $1,359 - $1,861	-26 Reduced 4.75%	521 $29,000
Q1 2022 Apr 21, 2022	BUY	$51.32 - $68.5 $28,072 - $37,469	547 New	547 $34,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

Bvf Inc San Francisco, CA

1.57M
Shares

$45.2 Million
1.44% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.41M
Shares

$40.6 Million
0.76% of portfolio
Prosight Management, LP Dallas, TX

1.03M
Shares

$29.6 Million
7.95% of portfolio
Logos Global Management LP San Francisco, CA

800K
Shares

$23 Million
3.05% of portfolio
Primecap Management CO Pasadena, CA

720K
Shares

$20.7 Million
0.02% of portfolio

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account